Table 2.
Univariate Logistic Regression with 12-Month Functional Decline/Death
Variable | Reference Group | Odds (95% CI) | p-value |
---|---|---|---|
VES Scores at baseline | 1.433 (1.252, 1.641) | <.0001 | |
Age | 1.130 (1.069, 1.194) | <.0001 | |
Race: African-American | White | 2.369 (1.163, 4.827) | 0.0175 |
Education: ≤ High school | > High school | 4.265 (2.004, 9.077) | 0.0002 |
Marital Status: Other | Married | 2.602 (1.156, 5.854) | 0.0209 |
Median Household Income (per 1000) | 0.979 (0.961, 0.997) | 0.0199 | |
Living Situation: Alone | Other | 1.446 (0.718, 2.909) | 0.3015 |
Employment: Employed | Other | 0.753 (0.207, 2.735) | 0.6661 |
Health Insurance: Medicare | Other | 0.747 (0.272, 2.051) | 0.5708 |
Weight: Overweight/Obese | Underweight/Normal | 1.886 (0.773, 4.601) | 0.1631 |
Charlson’s Comorbidity Index: ≥ 2 | < 2 | 2.173 (1.024, 4.611) | 0.0432 |
Stage: III | I – II | 3.609 (1.473, 8.842) | 0.0050 |
Chemotherapy: Yes | No | 0.538 (0.220, 1.319) | 0.1756 |
Hormonal Therapy: Yes | No | 0.707 (0.297, 1.683) | 0.4338 |
Type of Surgery: Lumpectomy | Mastectomy | 0.652 (0.301, 1.415) | 0.2793 |
None | Mastectomy | 3.750 (0.882, 15.942) | 0.0735 |
Lymph Node Dissection: Yes | No | 0.523 (0.215, 1.272) | 0.1531 |
Radiation Therapy: Yes | No | 0.597 (0.288, 1.239) | 0.1663 |
Biological Therapy: Yes | No | 1.318 (0.537, 3.239) | 0.5469 |
Neoadjuvant Therapy: Yes | No | 1.517 (0.692, 3.325) | 0.2975 |